Gene signature based on B cell predicts clinical outcome of radiotherapy and immunotherapy for patients with lung adenocarcinoma

Lung adenocarcinoma (LUAD) is the most common and lethal cancer worldwide. Radiotherapy (RT) is widely used at all stages of LUAD, and the development of immunotherapy substantially enhances the survival of LUAD patients. Although the emerging treatments for LUAD have improved prognosis, only a smal...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Med
Päätekijät: Han, Linzhi, Shi, Hongjie, Luo, Yuan, Sun, Wenjie, Li, Shuying, Zhang, Nannan, Jiang, Xueping, Gong, Yan, Xie, Conghua
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2020
Aiheet:
Cancer Biology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7774727/
https://ncbi.nlm.nih.gov/pubmed/33098370
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3561
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia